PARNAX LAB LTD. Share Price
PARNAX LAB LTD. Share Price Today
As of 3 Sep 2026, PARNAX LAB LTD. share price is ₹134.04. The stock opened at ₹143.00, compared to its previous close of ₹140.78. During today's trading session, PARNAX LAB LTD. share price moved in the range of ₹134.01 to ₹144.90, with an average price of ₹139.45 for the day. Looking at its last 52-week, the stock has touched a low of ₹108.03 and a high of ₹144.90.
PARNAX LAB LTD. Returns Calculator
About PARNAX LAB LTD.
Parnax Lab Limited is an India-based holding company. The Company is principally engaged in the business activities of manufacturing and export of pharmaceutical formulations. The Company operates through the trading of the pharmaceuticals and medicinal products segment. It is engaged in developing and delivering huge volumes of oral formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, special formulations for geriatrics, viscous products, suspensions, and others. Its product portfolio consists of pharmaceuticals, cosmetics, herbal, and nutraceuticals. Its cosmetics products include antidruf gel, EVE fairness acne care night cream for acne skin, EVE fairness scrub, and others. The Company provides companies with the service of developing the drug through Contract Research and Manufacturing Services (C.R.A.M.S) or manufacturing collaborations. The Company’s subsidiary is Naxpar Pharma Private Limited.
PARNAX LAB LTD. Financial Highlights
- Revenue: PARNAX LAB LTD. reported revenue of ₹252.32 crore in FY26 vs ₹189.42 crore in FY25. It showed an increase of 33.21% on a yearly basis.
- Operating Profit: PARNAX LAB LTD. reported an operating profit of ₹15.91 crore in FY26 vs ₹15.67 crore in FY25. It showed an increase of 1.53% on a year-on-year basis.
- Net Profit: PARNAX LAB LTD. reported a net profit of ₹11.80 crore in FY26 vs ₹11.54 crore in FY25. It showed an increase of 2.25% on a yearly basis.
PARNAX LAB LTD. Quarterly Result Highlights
- PARNAX LAB LTD. reported revenue of ₹56.95 crore in Jun 2026, compared with ₹71.62 crore in Mar 2026, representing a decrease of 20.48% on a quarter-on-quarter (QoQ) basis.
- PARNAX LAB LTD. reported an operating profit of ₹0.60 crore in Jun 2026, compared with ₹3.00 crore in Mar 2026, representing a decrease of 80.00% on a quarter-on-quarter (QoQ) basis.
- PARNAX LAB LTD. reported a profit of ₹0.43 crore in Jun 2026, compared with ₹2.18 crore in Mar 2026, reflecting a decrease of 80.28% on a QoQ basis.
- The earnings per share (EPS) of PARNAX LAB LTD. stood at ₹10.03 during Jun 2026.
| Sep 2025 | 0.00% |
|---|---|
| Dec 2025 | 0.00% |
| Mar 2026 | 0.00% |
| Jun 2026 | 0.00% |
PARNAX LAB LTD. Shareholder Returns
PARNAX LAB LTD. Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,63,180.00 | 38.28 | 5.55 | 13.74% | 0.61 | 17.33% | 93.24 | 0.83% | 0.48 | 10.90 |
| Divis Laboratories | 2,43,302.00 | 83.79 | 14.62 | 15.32% | 0.00 | 19.56% | 629.49 | 0.32% | 0.55 | 98.19 |
| Torrent Pharmaceuticals | 1,88,623.00 | 88.29 | 22.64 | 25.49% | 1.69 | 13.85% | 222.76 | 0.68% | 0.49 | 58.70 |
| Zydus Lifesciences | 1,16,114.00 | 25.00 | 4.24 | 18.59% | 0.31 | 17.35% | 237.30 | 0.09% | 0.33 | 35.38 |
| Cipla | 1,14,554.00 | 34.02 | 3.32 | 11.27% | 0.00 | 14.95% | 423.36 | 0.92% | 0.45 | 43.52 |
| Laurus Labs | 1,00,498.00 | 92.32 | 18.99 | 16.77% | 0.40 | 16.14% | 97.20 | 0.11% | 0.67 | 13.72 |
| Lupin | 98,312.20 | 17.73 | 4.38 | 23.76% | 0.04 | 24.88% | 659.00 | 0.84% | 0.57 | 129.18 |
| Dr. Reddy's Laboratories | 96,906.30 | 30.44 | 2.55 | 11.07% | 0.18 | 12.54% | 377.95 | 0.69% | 0.41 | 38.68 |
| Mankind Pharma | 97,467.00 | 47.54 | 6.03 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.44 | 49.37 |
| Aurobindo Pharma | 96,836.10 | 25.68 | 2.52 | 9.25% | 0.19 | 11.76% | 394.82 | 0.24% | 0.38 | 41.58 |
PARNAX LAB LTD. Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹187.74 | ₹188.71 | ₹167.61 | ₹163.03 |
| Other Income | ₹1.68 | ₹0.82 | ₹0.77 | ₹0.33 |
| Total Revenue | ₹189.41 | ₹189.53 | ₹168.38 | ₹163.36 |
| Total Expenses | ₹173.74 | ₹177.48 | ₹156.10 | ₹151.10 |
| Profit Before Tax | ₹15.67 | ₹12.05 | ₹12.28 | ₹12.26 |
| Tax | ₹4.14 | ₹2.42 | ₹3.65 | ₹4.01 |
| Profit After Tax | ₹11.54 | ₹9.62 | ₹8.63 | ₹8.26 |
| EPS - Basic | ₹10.03 | ₹8.37 | ₹7.80 | ₹9.70 |
| EPS - Diluted | ₹10.03 | ₹8.37 | ₹7.80 | ₹9.70 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹15.67 | ₹12.05 | ₹12.28 | ₹12.26 |
| Income before WC changes | ₹28.51 | ₹23.91 | ₹23.86 | ₹23.32 |
| Change in Assets | ₹8.14 | -₹13.07 | ₹9.27 | -₹33.68 |
| Change in Liabilities | -₹1.61 | ₹7.67 | -₹9.35 | ₹19.14 |
| Change in WC | ₹6.53 | -₹5.40 | -₹0.09 | -₹14.53 |
| Cash flow from Operations | ₹32.30 | ₹15.88 | ₹20.91 | ₹8.55 |
| Cash flow from Investing | -₹16.39 | -₹31.52 | -₹9.92 | -₹16.50 |
| Cash flow from Financing | -₹15.82 | ₹14.82 | -₹14.07 | ₹12.13 |
| Total Cash Flow | ₹0.09 | -₹0.82 | -₹3.08 | ₹4.18 |
| Cash (Start of the year) | ₹0.46 | ₹1.28 | ₹4.36 | ₹0.18 |
| Cash (End of the year) | ₹0.55 | ₹0.46 | ₹1.28 | ₹4.36 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹125.04 | ₹116.95 | ₹87.75 | ₹82.44 |
| Current Assets | ₹64.78 | ₹73.31 | ₹57.32 | ₹71.03 |
| Total Assets | ₹189.82 | ₹190.26 | ₹145.07 | ₹153.46 |
| Current Liabilities | ₹74.33 | ₹83.33 | ₹63.04 | ₹80.98 |
| Net Current Asset | -₹9.56 | -₹10.02 | -₹5.72 | -₹9.95 |
| Non-Current Liabilities | ₹32.24 | ₹35.24 | ₹19.77 | ₹24.21 |
| Equity Capital | ₹83.24 | ₹71.69 | ₹62.26 | ₹48.28 |
| Total Equity & Liabilities | ₹189.82 | ₹190.26 | ₹145.07 | ₹153.46 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹7.02 | ₹7.44 | ₹7.47 | ₹7.15 |
| Other Income | ₹0.71 | ₹0.54 | ₹0.37 | ₹0.16 |
| Total Revenue | ₹7.73 | ₹7.98 | ₹7.84 | ₹7.31 |
| Total Expenses | ₹5.87 | ₹5.53 | ₹6.22 | ₹6.53 |
| Profit Before Tax | ₹1.86 | ₹2.45 | ₹1.63 | ₹0.78 |
| Tax | ₹0.46 | ₹0.62 | ₹0.42 | ₹0.24 |
| Profit After Tax | ₹1.39 | ₹1.82 | ₹1.20 | ₹0.54 |
| EPS - Basic | ₹1.21 | ₹1.59 | ₹1.09 | ₹0.64 |
| EPS - Diluted | ₹1.21 | ₹1.59 | ₹1.09 | ₹0.64 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹1.86 | ₹2.45 | ₹1.63 | ₹0.78 |
| Income before WC changes | ₹1.44 | ₹2.34 | ₹1.80 | ₹1.60 |
| Change in Assets | -₹1.81 | -₹2.35 | -₹1.34 | -₹1.94 |
| Change in Liabilities | ₹0.68 | ₹0.11 | -₹0.73 | -₹0.02 |
| Change in WC | -₹1.14 | -₹2.24 | -₹2.07 | -₹1.96 |
| Cash flow from Operations | ₹0.28 | ₹0.08 | -₹0.28 | -₹0.36 |
| Cash flow from Investing | -₹0.19 | ₹0.30 | ₹0.14 | ₹0.00 |
| Cash flow from Financing | -₹0.02 | -₹1.21 | -₹2.92 | ₹4.59 |
| Total Cash Flow | ₹0.06 | -₹0.83 | -₹3.07 | ₹4.23 |
| Cash (Start of the year) | ₹0.44 | ₹1.27 | ₹4.33 | ₹0.10 |
| Cash (End of the year) | ₹0.50 | ₹0.44 | ₹1.27 | ₹4.33 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹14.02 | ₹14.20 | ₹14.87 | ₹15.38 |
| Current Assets | ₹10.69 | ₹8.04 | ₹6.50 | ₹8.16 |
| Total Assets | ₹24.72 | ₹22.24 | ₹21.37 | ₹23.53 |
| Current Liabilities | ₹1.74 | ₹1.06 | ₹1.84 | ₹9.63 |
| Net Current Asset | ₹8.96 | ₹6.98 | ₹4.65 | -₹1.47 |
| Non-Current Liabilities | ₹0.43 | ₹0.02 | ₹0.17 | ₹1.16 |
| Equity Capital | ₹22.54 | ₹21.15 | ₹19.35 | ₹12.75 |
| Total Equity & Liabilities | ₹24.72 | ₹22.24 | ₹21.37 | ₹23.53 |
| 2 Sep | 0L |
|---|---|
| 1 Sep | 0L |
| 31 Aug | 0L |
| 28 Aug | 0L |
| 27 Aug | 0L |
| Average | 0L |
Popular Stocks
PARNAX LAB LTD. Share Price FAQs
What is PARNAX LAB LTD. share price today?
PARNAX LAB LTD. share price is ₹134.04 as on 02 Sep, 2026, 15:27 IST.
How much is the Mutual Fund shareholding in PARNAX LAB LTD. shares?
The Mutual Fund Shareholding in PARNAX LAB LTD. was 0.00% at the end of Jun 2026.
What is the the 52-week high and low of PARNAX LAB LTD. shares ?
The 52-week high and low of PARNAX LAB LTD. share is ₹144.90 and ₹108.03 as of 02 Sep, 2026.
What is the market cap of PARNAX LAB LTD.?
The market capitalisation of PARNAX LAB LTD. is ₹160.17 Crores as on 02 Sep, 2026.
What are the stock symbols of PARNAX LAB LTD.?
The stock symbol of PARNAX LAB LTD. is PARNAXLAB on the NSE, 506128 on the BSE, and the ISIN is INE383L01019.
What was yesterday's closing price of PARNAX LAB LTD. shares ?
PARNAX LAB LTD. shares closed yesterday at ₹140.78 on NSE & ₹139.45 on BSE
How to buy PARNAX LAB LTD. shares?
To buy PARNAX LAB LTD. shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy PARNAX LAB LTD. shares on Holidays?
No, shares of PARNAX LAB LTD. or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell PARNAX LAB LTD. shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of PARNAX LAB LTD.?
The PE and PB ratio of PARNAX LAB LTD. is 17.46 and 1.64 respectively, as on 02 Sep, 2026, 15:27 IST.